Name | Ethyl [2-(4-chlorophenyl)-5-ethoxy-1,3-oxazol-4-yl]acetate |
---|---|
Synonyms |
[2-(4-chlorophenyl)-3H-imidazol-4-yl]methanol
ethyl-2-(4-chlorophenyl)-5-ethoxy-4-oxazole acetate [2-(4-chloro-phenyl)-5-ethoxy-oxazol-4-yl]-acetic acid ethyl ester ethyl 2-p-chlorophenyl-5-ethoxy-4-oxazoleacetate Y-9738 |
Description | Y-9738 is a hypolipidemic agent. |
---|---|
Related Catalog | |
In Vivo | Y-9738 is a hypolipidemic agent. At 100 mg/kg Y-9738 lowers the cholesterol level by 36% and clearly diminishes the intensity of the β-lipoprotein band with a tendency for the α-lipoprotein band to be intensified. Y-9738 causes a dose-dependent decrease in serum cholesterol, triglyceride and heparin-precipitable β-lipoprotein cholesterol. Furthermore, Y-9738 reduces the intensity of the β-lipoprotein band shown by electrophoresis, and increases that of the α-lipoprotein band[1]. |
Animal Admin | Male Sprague-Dawley rats are used in this work. Rats (140 to 180 g) are fed a high cholesterol diet for 10 days. This diet contains 1% cholesterol, 0.2% sodium cholate and 5% olive oil. Y-9738 is orally administered to the animals once a day throughout the experimental period. All animals are starved overnight (about 20 h) after the last treatment and sacrificed by carotid incision. Blood and liver are collected for lipid analysis[1]. |
References |
Density | 1.226g/cm3 |
---|---|
Boiling Point | 416.2ºC at 760 mmHg |
Molecular Formula | C15H16ClNO4 |
Molecular Weight | 309.74500 |
Flash Point | 205.5ºC |
Exact Mass | 309.07700 |
PSA | 61.56000 |
LogP | 3.49930 |
Index of Refraction | 1.53 |
Storage condition | 2-8℃ |
~% 59399-41-6 |
Literature: Yoshitomi Pharmaceutical Industries, Ltd. Patent: US4012412 A1, 1977 ; |